Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 64.62 points (-0.4%) at 16,379 as of Thursday, Aug. 7, 2014, 3:55 PM ET. The NYSE advances/declines ratio sits at 1,596 issues advancing vs. 1,415 declining with 129 unchanged. The Drugs industry as a whole closed the day down 1.1% versus the S&P 500, which was down 0.6%. Top gainers within the Drugs industry included Aoxing Pharmaceutical ( AXN), up 7.8%, Tianyin Pharmaceutical ( TPI), up 1.7%, Oragenics ( OGEN), up 6.4%, Heat Biologics ( HTBX), up 1.6% and Chembio Diagnostics ( CEMI), up 1.6%. TheStreet Ratings Group would like to highlight 3 stocks pushing the industry higher today: Heat Biologics ( HTBX) is one of the companies that pushed the Drugs industry higher today. Heat Biologics was up $0.06 (1.6%) to $3.87 on average volume. Throughout the day, 13,625 shares of Heat Biologics exchanged hands as compared to its average daily volume of 14,300 shares. The stock ranged in a price between $3.60-$3.87 after having opened the day at $3.60 as compared to the previous trading day's close of $3.81. Heat Biologics has a market cap of $24.8 million and is part of the health care sector. Shares are down 46.3% year-to-date as of the close of trading on Wednesday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more. Highlights from TheStreet Ratings analysis on HTBX go as follows: You can view the full analysis from the report here: Heat Biologics Ratings Report STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.